Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

multichem nz limited - cefuroxime sodium 802mg equivalent to cefuroxime 750 mg;   - powder for injection - 750 mg - active: cefuroxime sodium 802mg equivalent to cefuroxime 750 mg   - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available (see section 5.1). indications include - respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic arthritis. - obstetric and gynecological infections, pelvic inflammatory diseases. - gonorrhea particularly when penicillin is unsuitable. - other infections including septicemia, meningitis and peritonitis. - prophylaxis against infection in abdominal, pelvic, orthopedic, cardiac, pulmonary, esophageal and vascular surgery where there is increased risk from infection

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime;   - powder for injection - 1.5 g - active: cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 263mg equivalent to 250 mg cefuroxime;   - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent to 250 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime;   - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime   - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.

Malta - Engels - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 250 mg - antibacterials for systemic use

Malta - Engels - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 500 mg - antibacterials for systemic use

Ierland - Engels - HPRA (Health Products Regulatory Authority)

milpharm limited - cefuroxime axetil (amorphous) - film coated tablet - 250 milligram - cephalosporins and related substances - antibacterials for systemic use, second-generation cephalosporins - cefuroxime milpharm is indicated for the treatment of the infections listed below in adults and children from the age of 3 months • acute streptococcal tonsillitis and pharyngitis. • acute bacterial sinusitis. • acute otitis media. • acute exacerbations of chronic bronchitis. • cystitis. • pyelonephritis. • uncomplicated skin and soft tissue infections. • treatment of early lyme disease.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - cefuroxime sodium 1578mg equivalent to cefuroxime 1500 mg;   - powder for injection - 1.5 g - active: cefuroxime sodium 1578mg equivalent to cefuroxime 1500 mg   - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include:

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - cefuroxime sodium 789mg equivalent to cefuroxime 750 mg;   - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to cefuroxime 750 mg   - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include:

Malta - Engels - Medicines Authority

villerton invest s.a. rue edward steichen 14, 2540, luxembourg - cefuroxime - powder for solution for injection powder for suspension for injection - cefuroxime 250 mg - antibacterials for systemic use